REsponsiveness to CLOpidogrel and Stent-related Events in Acute Coronary. Reclose-ACS Registry.

Trial Profile

REsponsiveness to CLOpidogrel and Stent-related Events in Acute Coronary. Reclose-ACS Registry.

Completed
Phase of Trial: Phase IV

Latest Information Update: 31 Aug 2016

At a glance

  • Drugs Clopidogrel (Primary)
  • Indications Acute coronary syndromes; Stent thrombosis
  • Focus Therapeutic Use
  • Acronyms RECLOSE2-ACS
  • Most Recent Events

    • 22 Jul 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 11 Nov 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top